Penumbra Inc
NYSE:PEN

Watchlist Manager
Penumbra Inc Logo
Penumbra Inc
NYSE:PEN
Watchlist
Price: 267.56 USD -0.76% Market Closed
Market Cap: 10.3B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one PEN stock under the Base Case scenario is 155.21 USD. Compared to the current market price of 267.56 USD, Penumbra Inc is Overvalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PEN Relative Value
Base Case
155.21 USD
Overvaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.6
P/S
P/S
Price to Sales
8.6
vs History
66
vs Industry
13
Median 3Y
8.7
Median 5Y
10.8
Industry
2.2
Forward
7.5
More Details
735
P/E
P/E
Price to Earnings
735
vs History
12
vs Industry
0
Median 3Y
212.7
Median 5Y
157.6
Industry
22.5
Forward
72.3
More Details
61.1
P/OCF
P/OCF
Price to OCF
61.1
vs History
41
vs Industry
3
Median 3Y
61
Median 5Y
58.3
Industry
13.9
More Details
71
P/FCFE
P/FCFE
Price to FCFE
71
vs History
19
vs Industry
6
Median 3Y
-67
Median 5Y
-128.7
Industry
19.7
More Details
8.9
P/B
P/B
Price to Book Value
8.9
vs History
52
vs Industry
6
Median 3Y
8.2
Median 5Y
9.6
Industry
2.1
More Details
8.4
EV/S
EV/S
Enterprise Value to Sales
8.4
vs History
68
vs Industry
14
Median 3Y
8.4
Median 5Y
10.6
Industry
2.3
Forward
7.3
More Details
13.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.2
vs History
68
vs Industry
14
Median 3Y
13.3
Median 5Y
16.1
Industry
4.9
More Details
90.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
90.8
vs History
50
vs Industry
2
Median 3Y
79.5
Median 5Y
97.1
Industry
11.9
Forward
42.1
More Details
115.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
115.7
vs History
47
vs Industry
3
Median 3Y
103.1
Median 5Y
115.5
Industry
16.4
Forward
53.7
More Details
59.2
EV/OCF
EV/OCF
Enterprise Value to OCF
59.2
vs History
41
vs Industry
4
Median 3Y
59.1
Median 5Y
56.5
Industry
13.7
More Details
67.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
67.8
vs History
22
vs Industry
6
Median 3Y
59.3
Median 5Y
-128.6
Industry
17.2
More Details
8.6
EV/IC
EV/IC
Enterprise Value to IC
8.6
vs History
47
vs Industry
9
Median 3Y
7.5
Median 5Y
8.6
Industry
1.8
More Details

Multiples Across Competitors

PEN Competitors Multiples
Penumbra Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Penumbra Inc
NYSE:PEN
10.3B USD 8.6 735 90.8 115.7
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
139B USD 6.2 46.4 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
66B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
56.7B EUR 2.5 28.6 16.3 23.3
US
Edwards Lifesciences Corp
NYSE:EW
41.7B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.7B CNY 7.8 23.3 20.4 20.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.3 12.8 15.7

See Also

Summary
PEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEN stock valuation using valuation multiples.
Wall Street Estimates
PEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.